All sites C00-96,D32-33,D42-43,D45-47,D76 202 89.3 4.9 2.8 1.7 1.4
Mouth, pharynx C00-14 5 96.3 3.7 - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 0 100.0 - - - -
  Pharynx C01,C09-14 2 87.5 12.5 - - -
Digestive organs C15-26 39 88.8 2.5 4.1 3.0 1.5
  Oesophagus C15 5 95.7 - 4.3 - -
  Stomach C16 5 100.0 - - - -
  Small intestine C17 1 100.0 - - - -
  Colon C18 11 92.6 1.9 5.6 - -
  Rectum, rectosigmoid C19-20 7 100.0 - - - -
  Anus C21 - - - - - -
  Liver C22 4 100.0 - - - -
  Gallbladder, bile ducts C23-24 1 80.0 - - - 20.0
  Pancreas C25 6 48.3 13.8 13.8 17.2 6.9
  Other digestive organs C26 1 66.7 - - 33.3 -
Respiratory organs C30-39 31 63.4 22.9 7.2 3.9 2.6
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 29 61.6 24.0 7.5 4.1 2.7
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 6 100.0 - - - -
Skin, non-melanoma C44 13 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 1 100.0 - - - -
Breast C50 1 100.0 - - - -
Male genital organs C60-63 63 99.1 - - 0.6 0.3
  Prostate C61 61 99.0 - - 0.7 0.3
  Testis C62 1 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 15 90.5 1.4 2.7 4.1 1.4
  Kidney C64 5 85.2 - 7.4 3.7 3.7
  Bladder and urinary tract2 C65-68 9 93.6 2.1 - 4.3 -
Eye C69 0 - - - - 100.0
Brain, central nervous system C70-72,D32-33,D42-43 4 95.2 - 4.8 - -
Thyroid gland C73 1 100.0 - - - -
Other endocrine glands C74-75 0 50.0 50.0 - - -
Illdefined or unknown C76,C80 2 45.5 9.1 36.4 - 9.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 18 89.0 5.5 2.2 - 3.3
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 7 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 3 70.6 5.9 11.8 - 11.8
  Leukaemia C91-95 5 85.2 14.8 - - -
  Myelodysplastic syndromes D46 1 100.0 - - - -
  Myeloproliferaitive neoplasms D45,D47 1 66.7 - - - 33.3
Not included above
  Basal cell carcinoma of the skin 48 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.